EEF1A1 and metabolic dysfunction-associated steatotic liver disease: We previously demonstrated that inhibition of EEF1A1 with DB reduced hepatic steatosis in diet-induced obese mice with MASLD, and furthermore that DB decreased the proliferation and function in vitro of cell types that would contribute to liver inflammation and fibrosis (47).